Home -> Law Blog Directory -> International Law Blogs -> IP Dragon
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
International Law
: IP DragonRoger Bate determines China's Lethal Counterfeit Drugs Pattern
Mr Bate notices that China's food scandals follow a lethal pattern:
"Someone cuts a corner substituting an unsafe illegal product for a safe legal one; the legal entities trading in the product, which are often unaware of the illegal substitution, at first ignore the problem and then become embarrassed into a recall, often after pressure from foreign governments on Beijing. While Beijing threatens sanctions against the liable companies, including occasionally executing the guiltiest actors, it does little to change the likelihood of another scandal occurring."
Read Mr Bate's article 'Got Contaminated Milk?' here.
In the book 'Making a killing', Mr Bate puts the possibility of a complete victory over counterfeiters into perspective:
"Because counterfeiting represents such an easy and potentially lucrative opportunity for commercial profit, and because it spans industries as diverse as wine, electronics, and medicine, it likely will be never be eradicated. Still, if its characteristics are identified and its real effects understood, its impact may be mitigated substantially. Nowhere is this more evident-and important- than in the battle against the counterfeiting of lifesaving pharmaceuticals, a trade with dangerous implications for public health."
Read Mr Bate's book 'Making a killing' he wrote for the American Enterprise Institute for Public Policy Research here (free pdf-version).
Full post as published by IP Dragon on October 03, 2008 (boomark / email).
China Green Agriculture, Inc. 401(k) / ERISA Stock Fraud
China Green Agriculture, Inc. 401(k) / ERISA Stock Fraud
Asurion Recalls Counterfeit BlackBerry-branded Batteries
Asurion Recalls Counterfeit BlackBerry-branded Batteries
Infant Formula From China
FDA Warns it May be Contaminated Melamine
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
FDA Determines Menaflex Should Not Have Been Cleared for Marketing
Menaflex Collagen Scaffold FDA Says Should not Have Been Cleared
GlaxoSmithKline Pays $750 Million Over Defective Drugs
GlaxoSmithKline Pays $750 Million Over Defective Drugs

War on Counterfeit Drugs Intensifies
Bate: The High Cost of Cheaper Drugs
Will Roger Clemens Face Perjury Charges







